COVID-19 highlights importance of Waterloo blood startup
Shane Kilpatrick (MSc ’17, MBET ’18) is the CEO of Membio, a Canadian startup creating technology to manufacture red blood cells. In the Waterloo Magazine, he touches on the challenges and opportunities that COVID-19 presents for Canadian innovation.